# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-006889
Filing Date
2020-02-27
Accepted
2020-02-26 18:31:09
Documents
84
Period of Report
2019-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | acad-10k_20191231.htm iXBRL | 10-K | 3450056
2 | EX-4.3 | acad-ex43_475.htm | EX-4.3 | 31281
3 | EX-21.1 | acad-ex211_8.htm | EX-21.1 | 4462
4 | EX-23.1 | acad-ex231_10.htm | EX-23.1 | 10351
5 | EX-31.1 | acad-ex311_6.htm | EX-31.1 | 10343
6 | EX-31.2 | acad-ex312_54.htm | EX-31.2 | 10391
7 | EX-32.1 | acad-ex321_12.htm | EX-32.1 | 5649
8 | EX-32.2 | acad-ex322_55.htm | EX-32.2 | 6283
9 | GRAPHIC | gkxxj1gwvjut000002.jpg | GRAPHIC | 31796
10 | GRAPHIC | gkxxj1gwvjut000001.jpg | GRAPHIC | 38194
| Complete submission text file | 0001564590-20-006889.txt |  | 12621059

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA | acad-20191231.xsd | EX-101.SCH | 65243
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | acad-20191231_cal.xml | EX-101.CAL | 76574
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | acad-20191231_def.xml | EX-101.DEF | 201389
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | acad-20191231_lab.xml | EX-101.LAB | 578202
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | acad-20191231_pre.xml | EX-101.PRE | 419381
60 | EXTRACTED XBRL INSTANCE DOCUMENT | acad-10k_20191231_htm.xml | XML | 2670382

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50768 | Film No.: 20657704
SIC: 2834 Pharmaceutical Preparations